Atreca is a privately held biotechnology company developing novel therapeutics drawn from human immune responses, including effective anti-cancer immune responses. We are able to measure and analyze the structure of clinically relevant immune responses to identify the antibodies, T cell receptors, and targets that are key to successful treatment outcomes.
Market
Therapeutics
Location
Redwood City,
California,
USA
Coinvestors
Cormorant Asset Management, Wellington Management Company